Quantitative analysis of neuropeptide Y receptor association with β‐arrestin2 measured by bimolecular fluorescence complementation
Authors:
Open Access
- 24 May 2010
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 160 (4) , 892-906
Abstract
Background and purpose: β‐Arrestins are critical scaffold proteins that shape spatiotemporal signalling from seven transmembrane domain receptors (7TMRs). Here, we study the association between neuropeptide Y (NPY) receptors and β‐arrestin2, using bimolecular fluorescence complementation (BiFC) to directly report underlying protein–protein interactions.Experimental approach: Y1 receptors were tagged with a C‐terminal fragment, Yc, of yellow fluorescent protein (YFP), and β‐arrestin2 fused with the complementary N‐terminal fragment, Yn. After Y receptor–β‐arrestin association, YFP fragment refolding to regenerate fluorescence (BiFC) was examined by confocal microscopy in transfected HEK293 cells. Y receptor/β‐arrestin2 BiFC responses were also quantified by automated imaging and granularity analysis.Key results: NPY stimulation promoted association between Y1–Yc and β‐arrestin2–Yn, and the specific development of BiFC in intracellular compartments, eliminated when using non‐interacting receptor and arrestin mutants. Responses developed irreversibly and were slower than for downstream Y1 receptor–YFP internalization, a consequence of delayed maturation and stability of complemented YFP. However, β‐arrestin2 BiFC measurements delivered appropriate ligand pharmacology for both Y1 and Y2 receptors, and demonstrated higher affinity of Y1 compared to Y2 receptors for β‐arrestin2. Receptor mutagenesis combined with β‐arrestin2 BiFC revealed that alternative arrangements of Ser/Thr residues in the Y1 receptor C tail could support β‐arrestin2 association, and that Y2 receptor–β‐arrestin2 interaction was enhanced by the intracellular loop mutation H155P.Conclusions and implications: The BiFC approach quantifies Y receptor ligand pharmacology focused on the β‐arrestin2 pathway, and provides insight into mechanisms of β‐arrestin2 recruitment by activated and phosphorylated 7TMRs, at the level of protein–protein interaction.Keywords
This publication has 44 references indexed in Scilit:
- Guide to Receptors and Channels (GRAC), 4th editionBritish Journal of Pharmacology, 2009
- Plasma membrane diffusion of g protein-coupled receptor oligomersBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2008
- Novel Role of Y1 Receptors in the Coordinated Regulation of Bone and Energy HomeostasisJournal of Biological Chemistry, 2007
- Fluorescent Protein‐Based Cellular Assays Analyzed by Laser‐Scanning Microplate Cytometry in 1536‐Well Plate Format2006
- Characterization of Isoprenaline- and Salmeterol-Stimulated Interactions between β2-Adrenoceptors and β-Arrestin 2 Using β-Galactosidase Complementation in C2C12 CellsThe Journal of Pharmacology and Experimental Therapeutics, 2005
- Monitoring agonist‐promoted conformational changes of β‐arrestin in living cells by intramolecular BRETEMBO Reports, 2005
- Agonist and Inverse Agonist Actions of β-Blockers at the Human β2-Adrenoceptor Provide Evidence for Agonist-Directed SignalingMolecular Pharmacology, 2003
- β-Arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptorsProceedings of the National Academy of Sciences, 2003
- The Use of Bioluminescence Resonance Energy Transfer 2 to Study Neuropeptide Y Receptor Agonist-Induced β-Arrestin 2 InteractionThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET)Proceedings of the National Academy of Sciences, 2000